Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Aluminium adjuvants, typically referred to as 'alum', are the most commonly used adjuvants in human and animal vaccines worldwide, yet the mechanism underlying the stimulation of the immune system by alum remains unknown. Toll-like receptors are critical in sensing infections and are therefore common targets of various adjuvants used in immunological studies. Although alum is known to induce the production of proinflammatory cytokines in vitro, it has been repeatedly demonstrated that alum does not require intact Toll-like receptor signalling to activate the immune system. Here we show that aluminium adjuvants activate an intracellular innate immune response system called the Nalp3 (also known as cryopyrin, CIAS1 or NLRP3) inflammasome. Production of the pro-inflammatory cytokines interleukin-1beta and interleukin-18 by macrophages in response to alum in vitro required intact inflammasome signalling. Furthermore, in vivo, mice deficient in Nalp3, ASC (apoptosis-associated speck-like protein containing a caspase recruitment domain) or caspase-1 failed to mount a significant antibody response to an antigen administered with aluminium adjuvants, whereas the response to complete Freund's adjuvant remained intact. We identify the Nalp3 inflammasome as a crucial element in the adjuvant effect of aluminium adjuvants; in addition, we show that the innate inflammasome pathway can direct a humoral adaptive immune response. This is likely to affect how we design effective, but safe, adjuvants in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Recognition of microorganisms and activation of the immune response
Medzhitov, R. (2007) · Nature · doi:10.1038/nature06246 · Cited by 2,862
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,839
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
Pétrilli, V, Papin, S., Dostert, C., Mayor, A., Martinon, F., & Tschopp, J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402195 · Cited by 1,445
Kool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 993
Cited by
Items 101–200 of 1,002
Pulendran, B., Li, S., & Nakaya, H. I. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.006 · Cited by 380
“Despite the convincing in vitro studies, the question of whether Nalp3 is required for the adjuvanticity of alum remains controversial, with some studies demonstrating abrogation of antibody responses in Nalp3-deficient (Nlrp3 / ) mice (Eisenbarth et al., 2008; Li et al., 2008) andother studies showing partial or no e…”
BackgroundInfluentialde Zoete, M. R., Palm, N. W., Zhu, S., & Flavell, R. A. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016287 · Cited by 379
“Aluminum hydroxide, which is an adjuvant notable for its ability to induce allergic responses under certain conditions, can also trigger NLRP3 inflammasome activation (Li et al. 2007, 2008; Eisenbarth et al. 2008; Franchi and Nunez 2008; Kool et al. 2008; McKee et al. 2009).”
BackgroundSelf-citationTumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity
Aymeric, L., Apetoh, L., Ghiringhelli, F., Tesniere, A., Martins, I., Kroemer, G., Smyth, M. J., & Zitvogel, L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3566 · Cited by 380
“The Nlrp3 inflammasome was required for the production of IL-1β and IL-18 by macrophages in response to alum (25).”
BackgroundTRPM2 links oxidative stress to NLRP3 inflammasome activation
Zhong, Z., Zhai, Y., Liang, S., Mori, Y., Han, R., Sutterwala, F. S., & Qiao, L. (2013) · Nature Communications · doi:10.1038/ncomms2608 · Cited by 375
Self-citationRecombinant vaccines and the development of new vaccine strategies
Nascimento, I. P., & Leite, L. C. C. (2012) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2012007500142 · Cited by 367
“However, Richard Flavell’s group (15) recently suggested that they would activate an intracellular innate immune response system called Nalp3 inflammosome.”
BackgroundPannexin-1 Is Required for ATP Release during Apoptosis but Not for Inflammasome Activation
Qu, Y., Misaghi, S., Newton, K., Gilmour, L. L., Louie, S., Cupp, J. E., Dubyak, G. R., Hackos, D., & Dixit, V. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100478 · Cited by 363
“NLRP3-dependent caspase-1 activation in response to alum or silica (32, 33), NLRC4-dependent caspase-1 activation in response to S.”
BackgroundInflammasomes: guardians of cytosolic sanctity
Lamkanfi, M., & Dixit, V. M. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00730.x · Cited by 361
“Knockdown and pharmacological inhibition of pannexin-1 indicates that the hemichannel protein is critical for cryopyrin ⁄NALP3-dependent caspase-1 activation and IL-1b secretion in response to LPS + ATP (73).”
BackgroundInfluentialMalarial Hemozoin Activates the NLRP3 Inflammasome through Lyn and Syk Kinases
Tiemi Shio, M., Eisenbarth, S. C., Savaria, M., Vinet, A. F., Bellemare, M.-J., Harder, K. W., Sutterwala, F. S., Bohle, D. S., Descoteaux, A., Flavell, R. A., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000559 · Cited by 364
“Consistent with other crystals that induce inflammasome activation [15,16,17], we found that Hz-induced IL-1b seems to be dependent on its internalization (Fig.”
BackgroundSelf-citationKool, M., Willart, M. A. M., van Nimwegen, M., Bergen, I., Pouliot, P., Virchow, J. C., Rogers, N., Osorio, F., Reis e Sousa, C., Hammad, H., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.015 · Cited by 357
Inflammasomes: current understanding and open questions
Bauernfeind, F., Ablasser, A., Bartok, E., Kim, S., Schmid-Burgk, J., Cavlar, T., & Hornung, V. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0567-4 · Cited by 359
“A similar mechanism seems to be engaged by aluminum salts that are commonly used as adjuvants in vaccines [75, 78, 79].”
BackgroundNOD-Like Receptors: Versatile Cytosolic Sentinels
Motta, V., Soares, F., Sun, T., & Philpott, D. J. (2015) · Physiological Reviews · doi:10.1152/physrev.00009.2014 · Cited by 353
“Environmental irritants such as alum, asbestos, nanoparticles, and silica have also been demonstrated to activate the NLRP3 inflammasome (56, 109, 220, 292).”
BackgroundMechanism of action of clinically approved adjuvants
Lambrecht, B. N., Kool, M., Willart, M. A., & Hammad, H. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.01.004 · Cited by 354
Molecular mechanisms involved in inflammasome activation
Bryant, C., & Fitzgerald, K. A. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.06.002 · Cited by 347
The Inflammasomes in Kidney Disease
Anders, H.-J., & Muruve, D. A. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080798 · Cited by 351
Programming dendritic cells to induce TH2 and tolerogenic responses
Pulendran, B., Tang, H., & Manicassamy, S. (2010) · Nature Immunology · doi:10.1038/ni.1894 · Cited by 355
“Furthermore, it was recently demonstrated that alum, a classic T H 2 adjuvant, signals through the NALP3 inflammasom”
BackgroundWillingham, S. B., Allen, I. C., Bergstralh, D. T., Brickey, W. J., Huang, M. T.-H., Taxman, D. J., Duncan, J. A., & Ting, J. P.-Y. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900138 · Cited by 348
Inflammasomes: too big to miss
Stutz, A., Golenbock, D. T., & Latz, E. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40599 · Cited by 346
Ross, P. J., Sutton, C. E., Higgins, S., Allen, A. C., Walsh, K., Misiak, A., Lavelle, E. C., McLoughlin, R. M., & Mills, K. H. G. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003264 · Cited by 330
“It had previously been reported that alum functions as an adjuvant by activation of the Nlrp3 inflammasome [20,21], although this has been questioned by others [22].”
BackgroundSignalling adaptors used by Toll-like receptors: An update
Kenny, E. F., & O’Neill, L. A. J. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.010 · Cited by 332
“Similar to the effect in neurons, the adjuvant effect of Alum may be due to an anti-apoptotic effect via Akt in cell types yet to be defined.”
BackgroundInfluentialJoosten, L. A. B., Netea, M. G., Mylona, E., Koenders, M. I., Malireddi, R. K. S., Oosting, M., Stienstra, R., van de Veerdonk, F. L., Stalenhoef, A. F., Giamarellos‐Bourboulis, E. J., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27667 · Cited by 328
Nanoparticles and innate immunity: new perspectives on host defence
Boraschi, D., Italiani, P., Palomba, R., Decuzzi, P., Duschl, A., Fadeel, B., & Moghimi, S. M. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.013 · Cited by 310
Mascanfroni, I. D., Yeste, A., Vieira, S. M., Burns, E. J., Patel, B., Sloma, I., Wu, Y., Mayo, L., Ben-Hamo, R., Efroni, S., et al. (2013) · Nature Immunology · doi:10.1038/ni.2695 · Cited by 329
The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation
Wang, J., Peng, Y., Xu, H., Cui, Z., & Williams, R. O. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01744-7 · Cited by 327
Inflammasome-independent regulation of IL-1-family cytokines
Netea, M. G., van de Veerdonk, F. L., van der Meer, J. W. M., Dinarello, C. A., & Joosten, L. A. B. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112306 · Cited by 326
Hu, B., Elinav, E., Huber, S., Strowig, T., Hao, L., Hafemann, A., Jin, C., Wunderlich, C., Wunderlich, T., Eisenbarth, S. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307575110 · Cited by 326
“Inflammasomes could be activated by a diverse range of microbial, stress, and damage signals, which leads to the activation of caspase-1 and the subsequent maturation and secretion of proinflammatory cytokines IL-1β and IL-18 (27-32).”
BackgroundSelf-citationFunction and regulation of IL‐1α in inflammatory diseases and cancer
Malik, A., & Kanneganti, T. (2018) · Immunological Reviews · doi:10.1111/imr.12615 · Cited by 327
Prokopowicz, Z. M., Arce, F., Biedron, R., Chiang, C. L.-L., Ciszek, M., Katz, D. R., Nowakowska, M., Zapotoczny, S., Marcinkiewicz, J., & Chain, B. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902606 · Cited by 325
“Recent studies also suggest that many classical adjuvants work by promoting the innate/adaptive axis (3).”
BackgroundAlum adjuvant: some of the tricks of the oldest adjuvant
Kool, M., Fierens, K., & Lambrecht, B. N. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.038943-0 · Cited by 318
Manganese salts function as potent adjuvants
Zhang, R., Wang, C., Guan, Y., Wei, X., Sha, M., Yi, M., Jing, M., Lv, M., Guo, W., Xu, J., et al. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00669-w · Cited by 313
Akdis (2020) · doi:10.1111/pai.13189 · Cited by 320
Exosome-like Nanoparticles from Ginger Rhizomes Inhibited NLRP3 Inflammasome Activation
Chen, X., Zhou, Y., & Yu, J. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00246 · Cited by 311
Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders
Fukata, M., Vamadevan, A. S., & Abreu, M. T. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.06.005 · Cited by 320
ATP release and purinergic signaling in NLRP3 inflammasome activation
Gombault, A., Baron, L., & Couillin, I. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00414 · Cited by 309
“…pollutants including silica and asbestos (Dostert et al., 2008; Halle et al., 2008), from vaccines such as aluminum salt (alum) adjuvant (Eisenbarth et al., 2008) or from endogenous metabolic stresses such as high concentration of glucose (Schroder et al., 2010), cholesterol (Duewell et…”
BackgroundInfluentialMechanisms of interleukin-1β release
Eder, C. (2009) · Immunobiology · doi:10.1016/j.imbio.2008.11.007 · Cited by 307
Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants
Maisonneuve, C., Bertholet, S., Philpott, D. J., & De Gregorio, E. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400478111 · Cited by 303
Mechanisms of inflammation in gout
Busso, N., & So, A. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2952 · Cited by 295
“Th e list of NRLP3 triggers is currently ever expanding, and includes alum, hemozoin and DNA [29-31].”
BackgroundMetalloimmunology: The metal ion-controlled immunity
(2020) · Advances in Immunology · doi:10.1016/bs.ai.2019.11.007 · Cited by 292
Interleukin-5 and IL-5 receptor in health and diseases
TAKATSU, K. (2011) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.87.463 · Cited by 297
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy
Demento, S. L., Eisenbarth, S. C., Foellmer, H. G., Platt, C., Caplan, M. J., Mark Saltzman, W., Mellman, I., Ledizet, M., Fikrig, E., Flavell, R. A., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.034 · Cited by 290
“Thus, the LPS-modified particles alone offered both signals necessary to activate the TLR and NLRP3 inflammasome pathways, unlike alum [1], which requires LPS stimulation in vitro and endogenous signals in vivo for inflammasome activation.”
BackgroundSelf-citationThe NLRP3 inflammasome: Contributions to intestinal homeostasis
Zaki, M. H., Lamkanfi, M., & Kanneganti, T.-D. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.02.002 · Cited by 290
Adjuvants: Classification,Modus Operandi, and Licensing
Apostólico, J. D. S., Lunardelli, V. A. S., Coirada, F. C., Boscardin, S. B., & Rosa, D. S. (2016) · Journal of Immunology Research · doi:10.1155/2016/1459394 · Cited by 287
“Instead, they are sensed by NOD-like receptors (NLRs) through direct activation of NLRP3/NALP3 inflammasome complex or by the release of uric acid [18, 20, 21].”
Particulate vaccines: on the quest for optimal delivery and immune response
De Temmerman, M.-L., Rejman, J., Demeester, J., Irvine, D. J., Gander, B., & De Smedt, S. C. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.04.006 · Cited by 286
NLR functions beyond pathogen recognition
Kufer, T. A., & Sansonetti, P. J. (2011) · Nature Immunology · doi:10.1038/ni.1985 · Cited by 279
“However, the contribution of NLRP3 activation in alum-mediated adaptive immune responses is currently under discussion, and further studies are needed to establish its physiological rol”
BackgroundSensing damage by the NLRP3 inflammasome
Leemans, J. C., Cassel, S. L., & Sutterwala, F. S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01043.x · Cited by 281
“Inhibition of the potassium efflux in vitro by increasing extracellular potassium concentrations results in the abrogation of NLRP3 inflammasome activation (32, 33, 37).”
Self-citationThe Control of Adaptive Immune Responses by the Innate Immune System
Schenten, D., & Medzhitov, R. (2011) · Advances in Immunology · doi:10.1016/b978-0-12-387664-5.00003-0 · Cited by 279
Shimada, T., Park, B. G., Wolf, A. J., Brikos, C., Goodridge, H. S., Becker, C. A., Reyes, C. N., Miao, E. A., Aderem, A., Götz, F., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2009.12.008 · Cited by 274
“, 2008), alum(Eisenbarth et al., 2008; Franchi and Nunez, 2008; Hornung et al., 2008; Kool et al., 2008; Li et al., 2008), and hemozoin (Dostert et al.”
BackgroundThe path to a successful vaccine adjuvant – ‘The long and winding road’
O’Hagan, D. T., & De Gregorio, E. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.02.009 · Cited by 274
Innate Immune Recognition in Infectious and Noninfectious Diseases of the Lung
Opitz, B., van Laak, V., Eitel, J., & Suttorp, N. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1427so · Cited by 274
NOD-Like Receptors: Master Regulators of Inflammation and Cancer
Saxena, M., & Yeretssian, G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00327 · Cited by 274
Israeli, E., Agmon-Levin, N., Blank, M., & Shoenfeld, Y. (2009) · Lupus · doi:10.1177/0961203309345724 · Cited by 271
Desert Dust Exposure Is Associated with Increased Risk of Asthma Hospitalization in Children
Kanatani, K. T., Ito, I., Al-Delaimy, W. K., Adachi, Y., Mathews, W. C., & Ramsdell, J. W. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201002-0296oc · Cited by 268
Multiple cathepsins promote pro-IL-1β synthesis and NLRP3-mediated IL-1β activation
Orlowski, G. M., Colbert, J. D., Sharma, S., Bogyo, M., Robertson, S. A., & Rock, K. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500509 · Cited by 268
Sun, B., Ji, Z., Liao, Y.-P., Wang, M., Wang, X., Dong, J., Chang, C. H., Li, R., Zhang, H., Nel, A. E., et al. (2013) · ACS Nano · doi:10.1021/nn404211j · Cited by 262
“Alum failed to boost OVA-specific antibody responses in NLRP3, ASC, and caspase-1 knockout mice.(24) Simi-”
BackgroundMethodInfluentialRegulation of Inflammation- and Infection-Driven Hematopoiesis
Boettcher, S., & Manz, M. G. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.004 · Cited by 259
“The vaccine adjuvant alum, which is a known inducer of IL-1b secretion by stimulating the NLRP3 inflammasome [62], stimulates a hematopoietic response in an IL-1 receptor 1-dependent manner that phenocopies LPS-induced emergency granulopoiesis [63].”
BackgroundTregoning, J. S., Russell, R. F., & Kinnear, E. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1415684 · Cited by 263
Dubensky, T. W., & Reed, S. G. (2010) · Seminars in Immunology · doi:10.1016/j.smim.2010.04.007 · Cited by 259
ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation
Riteau, N., Baron, L., Villeret, B., Guillou, N., Savigny, F., Ryffel, B., Rassendren, F., Le Bert, M., Gombault, A., & Couillin, I. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.144 · Cited by 257
“However, cytoskeleton is not necessary for IL1b secretion.(3) Here, we show that ATP leakage is completely”
BackgroundThe Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery
Xia, Y., Xie, Y., Yu, Z., Xiao, H., Jiang, G., Zhou, X., Yang, Y., Li, X., Zhao, M., Li, L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.070 · Cited by 257
“, 2016), and inflammasome (NLRP3) is involved in alum’s adjuvanticity (Eisenbarth et al., 2008).”
Ma, Q. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000629 · Cited by 240
XIAP Restricts TNF- and RIP3-Dependent Cell Death and Inflammasome Activation
Yabal, M., Müller, N., Adler, H., Knies, N., Groß, C. J., Damgaard, R. B., Kanegane, H., Ringelhan, M., Kaufmann, T., Heikenwälder, M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.008 · Cited by 255
“Alum induces a sustained inflammatory response primarily driven by NLRP3 inflammasome activation in inflammatory CD11c+ DCs (Eisenbarth et al., 2008; Kool et al., 2008).”
Witzenrath, M., Pache, F., Lorenz, D., Koppe, U., Gutbier, B., Tabeling, C., Reppe, K., Meixenberger, K., Dorhoi, A., Ma, J., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003143 · Cited by 254
Engineered immunogen binding to alum adjuvant enhances humoral immunity
Moyer, T. J., Kato, Y., Abraham, W., Chang, J. Y. H., Kulp, D. W., Watson, N., Turner, H. L., Menis, S., Abbott, R. K., Bhiman, J. N., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0753-3 · Cited by 252
The Role of Uric Acid as an Endogenous Danger Signal in Immunity and Inflammation
Ghaemi-Oskouie, F., & Shi, Y. (2011) · Current Rheumatology Reports · doi:10.1007/s11926-011-0162-1 · Cited by 249
“It also was reported that NLRP3 is required for the ability of alum to act as an adjuvant in antibody induction [37], and that the presence of alum in vaccine preparations induced the production of uric acid, which subsequently triggers APC activation [38].”
BackgroundControlling timing and location in vaccines
Irvine, D. J., Aung, A., & Silva, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.019 · Cited by 254
Ritter, M., Gross, O., Kays, S., Ruland, J., Nimmerjahn, F., Saijo, S., Tschopp, J., Layland, L. E., & Prazeres da Costa, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010337107 · Cited by 243
“To date, several mechanisms have been associated with Nlrp3 inflammasome activation such as phagocytosis, which appears to involve lysosomal rupture and release of cathepsin B into the cytosol (18, 20).”
BackgroundIp, W. K. E., & Medzhitov, R. (2015) · Nature Communications · doi:10.1038/ncomms7931 · Cited by 244
“…of either biological or non-biological origin can activate the NLRP3 inflammasome, including ATP 19 , bacterial pore-forming toxins 19, 20 , alum 21 , and several types of crystals 22, 23, 24, 25 , suggesting that NLRs can sense common cellular stress events that are triggered by these diverse…”
Recent progress in adjuvant discovery for peptide-based subunit vaccines
Azmi, F., Ahmad Fuaad, A. A. H., Skwarczynski, M., & Toth, I. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.27332 · Cited by 239
“Additional in vitro studies support this data; Th2 cell priming and antibody response to OVA or human serum albumin (HSA) co-delivered with alum were also reduced in NLRP3 deficient mice.(30) Furthermore, a link between the innate inflammasome pathway and the adaptive humoral response has been found.”
ResultInflammasomes and adaptive immune responses
Deets, K. A., & Vance, R. E. (2021) · Nature Immunology · doi:10.1038/s41590-021-00869-6 · Cited by 238
Diverse Activators of the NLRP3 Inflammasome Promote IL-1β Secretion by Triggering Necrosis
Cullen, S. P., Kearney, C. J., Clancy, D. M., & Martin, S. J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.05.003 · Cited by 235
Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens
Wegmann, F., Gartlan, K. H., Harandi, A. M., Brinckmann, S. A., Coccia, M., Hillson, W. R., Kok, W. L., Cole, S., Ho, L.-P., Lambe, T., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2344 · Cited by 235
Self-citationPerricone, C., Colafrancesco, S., Mazor, R. D., Soriano, A., Agmon-Levin, N., & Shoenfeld, Y. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.10.004 · Cited by 234
Sensing pathogens and danger signals by the inflammasome
Pedra, J. H., Cassel, S. L., & Sutterwala, F. S. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.01.006 · Cited by 233
Self-citationUnleashing the therapeutic potential of NOD-like receptors
Geddes, K., Magalhães, J. G., & Girardin, S. E. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2783 · Cited by 232
Alum adjuvanticity: Unraveling a century old mystery
De Gregorio, E., Tritto, E., & Rappuoli, R. (2008) · European Journal of Immunology · doi:10.1002/eji.200838648 · Cited by 232
Targeting innate immune pathways for cancer immunotherapy
Cao, L. L., & Kagan, J. C. (2023) · Immunity · doi:10.1016/j.immuni.2023.07.018 · Cited by 216
The Caspase-1 Inflammasome: A Pilot of Innate Immune Responses
Yu, H. B., & Finlay, B. B. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.08.007 · Cited by 224
Mechanisms of uric acid crystal‐mediated autoinflammation
Martinon, F. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00860.x · Cited by 224
“Fubini B, Hubbard A. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis.”
BackgroundInfluentialThe role of the NLRP3 inflammasome in gout
McDermott, M., Kingsbury, S., & Conaghan (2011) · Journal of Inflammation Research · doi:10.2147/jir.s11330 · Cited by 219
Mesoporous Silica as a Versatile Platform for Cancer Immunotherapy
Nguyen, T. L., Choi, Y., & Kim, J. (2019) · Advanced Materials · doi:10.1002/adma.201803953 · Cited by 219
Innate and adaptive immune responses to cell death
Rock, K. L., Lai, J., & Kono, H. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01040.x · Cited by 221
“tos, alum, calcium pyrophosphate, and cholesterol crystals (25, 80, 82, 83, 85).”
BackgroundThe NLRP3 inflammasome: A sensor of immune danger signals
Cassel, S. L., Joly, S., & Sutterwala, F. S. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.05.002 · Cited by 217
“Cruz CM, Rinna A, Forman HJ, Ventura AL, Persechini PM, Ojcius DM. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages.”
BackgroundMethodInfluentialSelf-citationAdjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
Ho, N. I., Huis in 't Veld, L. G. M., Raaijmakers, T. K., & Adema, G. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02874 · Cited by 216
Mok, C. C., Ho, L. Y., Fong, L. S., & To, C. H. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201393 · Cited by 213
Mechanism of action of licensed vaccine adjuvants
Tritto, E., Mosca, F., & De Gregorio, E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.084 · Cited by 213
Scaffold proteins and immune-cell signalling
Shaw, A. S., & Filbert, E. L. (2009) · Nature Reviews Immunology · doi:10.1038/nri2473 · Cited by 210
Interleukin-1 as Innate Mediator of T Cell Immunity
Van Den Eeckhout, B., Tavernier, J., & Gerlo, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.621931 · Cited by 213
The spectrum of post-vaccination inflammatory CNS demyelinating syndromes
Karussis, D., & Petrou, P. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.10.003 · Cited by 209
“Aluminium interferes with lysosomal functions and stimulates the production and secretion of cytokines such as IL-1b; IL-18 and IL-33 [128,131].”
BackgroundLack of the purinergic receptor P2X7 results in resistance to contact hypersensitivity
Weber, F. C., Esser, P. R., Müller, T., Ganesan, J., Pellegatti, P., Simon, M. M., Zeiser, R., Idzko, M., Jakob, T., & Martin, S. F. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092489 · Cited by 207
Kuroda, E., Ishii, K. J., Uematsu, S., Ohata, K., Coban, C., Akira, S., Aritake, K., Urade, Y., & Morimoto, Y. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.019 · Cited by 207
“Silica, alum and ATP induced LPS-primed macrophages to produce IL-1b and IL-18, which is in agreement with previous reports (Cassel et al., 2008; Dostert et al., 2008; Eisenbarth et al., 2008; Hornung et al., 2008).”
InfluentialIdentification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants
Marty-Roix, R., Vladimer, G. I., Pouliot, K., Weng, D., Buglione-Corbett, R., West, K., MacMicking, J. D., Chee, J. D., Wang, S., Lu, S., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.683011 · Cited by 204
“Of note, the role of NLRP3 activation by alum in vaccinations is controversial because there are several reports with contrasting results (5, 13, 15, 16).”
NLRP3 Inflammasome Activation Induced by Engineered Nanomaterials
Sun, B., Wang, X., Ji, Z., Li, R., & Xia, T. (2013) · Small · doi:10.1002/smll.201201962 · Cited by 204
New Insights into Mechanisms Controlling the NLRP3 Inflammasome and Its Role in Lung Disease
De Nardo, D., De Nardo, C. M., & Latz, E. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.09.007 · Cited by 205
“A crucial role for the NLRP3 inflammasome in development of allergic airway inflammation was described in both an adjuvant-dependent (alumOVA) and an adjuvant-free (OVA) model of allergic asthma.(84,85) Th2 cell priming was impaired in mice deficient in Nlrp3, Asc, or caspase-1, as demonstrated by decreased OVA-specif…”
BackgroundChitosan but Not Chitin Activates the Inflammasome by a Mechanism Dependent upon Phagocytosis
Bueter, C. L., Lee, C. K., Rathinam, V. A. K., Healy, G. J., Taron, C. H., Specht, C. A., & Levitz, S. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.274936 · Cited by 209
Immunomodulatory properties of the vaccine adjuvant alum
Oleszycka, E., & Lavelle, E. C. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.12.007 · Cited by 207
Regulation of the T Cell Response by CD39
Takenaka, M. C., Robson, S., & Quintana, F. J. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.04.009 · Cited by 207
“The importance of the NLRP3 inflammasome in the T-cell response is highlighted by the decrease in contact hypersensitivity (100) and Th1 and Th17 responses (101, 102) observed in NLPR3-deficient mice.”
BackgroundAndorko, J. I., & Jewell, C. M. (2017) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10063 · Cited by 202
“inflammasome signaling, other work demonstrates these outcomes are not a feature of all particulate systems.(3,4,11,27,67,68) In a study from Vaine et al.”
BackgroundNOD-like receptors and the innate immune system: Coping with danger, damage and death
Kersse, K., Bertrand, M. J. M., Lamkanfi, M., & Vandenabeele, P. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.09.003 · Cited by 201
“Schistosoma mansoni) because P2X7R-deficient macrophages secrete similar amounts of IL-1b as wild-type macrophages [101,136,167–169].”
BackgroundZeng, X., Wei, Y.-L., Huang, J., Newell, E. W., Yu, H., Kidd, B. A., Kuhns, M. S., Waters, R. W., Davis, M. M., Weaver, C. T., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.06.011 · Cited by 202
Giles, B. M., & Ross, T. M. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.01.100 · Cited by 199
“Aluminum salts enhance antigen uptake by antigen presenting cells and stimulate a pro-inflammatory response via activation of the NOD-like receptor protein 3 inflammasome pathway [55].”
BackgroundThe Jekyll and Hyde Functions of Caspases
Yi, C. H., & Yuan, J. (2009) · Developmental Cell · doi:10.1016/j.devcel.2008.12.012 · Cited by 200
“A recent study proposes that the NALP3 inflammasome mediates the immunostimulatory properties of aluminum adjuvants, which can form insoluble particles, in a similar manner as described for uric acid crystals (Eisenbarth et al., 2008).”
Metadata
- Authors
- Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A.
- Affiliations
- Yale University (US)
- University of Iowa (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Flavell, Richard A.
- Venue
- Nature
- Published
- 2008-05-21
- Volume
- 453
- Issue
- 7198
- Pages
- 1122-1126
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4804622
- OpenAlex
- W1979991507
- Cited by
- 1,542
- References
- 45
- Citations by year
- 2026: 34 · 2025: 43 · 2024: 54 · 2023: 56 · 2022: 52 · 2021: 81 · 2020: 62 · 2019: 53 · 2018: 74 · 2017: 81 · 2016: 91 · 2015: 85 · 2014: 91 · 2013: 125 · 2012: 132
- FWCI
- 57.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Bill and Melinda Gates Foundation
- National Institutes of Health
- National Heart, Lung, and Blood Institute (T32HL007974)
- National Institute of Allergy and Infectious Diseases (K08AI065517)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32AR007016)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- NLRP3 inflammasome, aluminum hydroxide adjuvant, vaccine adjuvants, innate immunity, macrophages, IL-1β, IL-18, caspase-1, ASC, humoral antibody response, adaptive immune response, Toll-like receptors, complete Freund's adjuvant
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Adjuvants, Immunologic, Alum Compounds, Animals, Antibodies, Carrier Proteins, Cytoskeletal Proteins, Enzyme Activation, T-Lymphocytes, Helper-Inducer, Immunity, Innate, Inflammation, Macrophages, Mice, Inbred C57BL, Potassium, Cell Death, Caspase 1, Interleukin-18, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.